When drugs in development today hit the marketplace in 2020, they will need evidence of economic and clinical value results to be commercially successful
Michael N. Abrams, MA, Numerof & Associates
Advertisement
Articles by Michael N. Abrams, MA, Numerof & Associates
Advertisement
Latest Updated Articles
- Pharma's stake in comparative effectiveness research
Published: December 30th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
New Report Cautions That China’s Pharma Dominance Poses Growing Risks to US Drug Supply Chain
2
Novartis Unveils Expansive North Carolina Manufacturing Hub to Strengthen US Drug Supply Chain
3
How CNPVs Could Reshape US Drug Manufacturing
4
Pharma Pulse: Regulatory Crucible, China Supply Risk, and Texting Triumphs in Diabetes Care
5
